Environmental Toxins Linked to Autoimmune Disease Through Protein Modifications

Idaho State University researchers are studying how exposure to asbestos and other environmental toxins triggers autoimmune diseases by examining changes to proteins in the body. The team discovered that exposure to Libby asbestiform amphibole, a specific asbestos type mined in Montana, leads to elevated autoantibodies that mistakenly attack the body's own cells and tissues. Their investigation into how toxins chemically modify proteins without altering genetic code could reveal new therapeutic approaches for the millions affected by autoimmune conditions.

Autoimmune diseases occur when the body's immune defenses malfunction, producing antibodies that attack the body's own tissues rather than external threats like bacteria or viruses. This misdirected immune response causes inflammation, pain, and progressive cell damage. Idaho State University researchers are investigating a specific mechanism: how environmental toxins such as asbestos chemically alter proteins after they're already formed in the body, without changing the underlying genetic instructions.

The research focuses on Libby asbestiform amphibole, an asbestos variety extracted from Montana mines. The team hypothesizes that when toxins chemically modify proteins, these altered versions may appear foreign to the immune system, triggering it to produce autoantibodies against what should be recognized as the body's own molecules. By identifying which proteins change and how these modifications affect immune recognition, scientists hope to uncover therapeutic strategies applicable to millions of autoimmune disease patients.